Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fizzy-related protein homolog (FZR1) is a substrate-specific adaptor protein for the anaphase-promoting complex/cyclosome (APC/C), playing an essential role in the controlled degradation of cell cycle regulators to ensure proper progression through mitosis and maintenance of genomic stability[1][2]. FZR1 associates with APC/C following CDC20 dissociation in late mitosis and promotes the ubiquitination of substrates such as cyclin B and securin, allowing correct anaphase initiation and mitotic exit[1][2]. Phosphorylation cycles regulate FZR1 activity, especially at the G1/S checkpoint and in response to DNA damage, where it is implicated in halting mitotic progression and promoting DNA repair[1][2]. Beyond its cell cycle functions, FZR1/CDH1 regulates neurodevelopment, controlling neuronal survival, axonal outgrowth, and synapse function[4]. Pathogenic mutations in FZR1 result in developmental and epileptic encephalopathy and associations with neurodevelopmental disorders, while altered expression or dysregulation is implicated in cancer and other diseases[2][4]. Research targeting FZR1 for therapeutics is ongoing, with diagnostic and prognostic biomarker potential in oncology and neurology[2][4].
Modulators of FZR1 would affect APC/C-mediated ubiquitination leading to altered degradation of cell cycle regulators such as cyclin B and securin, potentially inducing cell-cycle arrest or apoptosis in cancer cells[2]. Indirect regulation of DNA damage response via partnership with p53 and ubiquitination of downstream effectors[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fizzy-related protein homolog (FZR1).